Cover Image

<i>Garcinia cambogia</i> Ameliorates Non-Alcoholic Fatty Liver Disease by Inhibiting Oxidative Stress-Mediated Steatosis and Apoptosis through NRF2-ARE Activation

Excessive free fatty acids (FFAs) causes reactive oxygen species (ROS) generation and non-alcoholic fatty liver disease (NAFLD) development. <i>Garcinia cambogia</i> (<i>G. cambogia</i>) is used as an anti-obesity supplement, and its protective potential against NAFLD has bee...

Full description

Saved in:

Bibliographic Details
Main Authors:	Joo-Hui Han (Author), Min-Ho Park (Author), Chang-Seon Myung (Author)
Format:	Book
Published:	MDPI AG, 2021-07-01T00:00:00Z.
Subjects:	article
Online Access:	Connect to this object online.
Tags:	Add Tag No Tags, Be the first to tag this record!

Similar Items

Statistical Design of Sustained-Release Tablet <i>Garcinia cambogia</i> Extract and Bioconverted Mulberry Leaf Extract for Anti-Obesity
by: Hye-Jin Lee, et al.
Published: (2020)

Interaction of <i>Garcinia cambogia</i> (Gaertn.) Desr. and Drugs as a Possible Mechanism of Liver Injury: The Case of Montelukast
by: Silvia Di Giacomo, et al.
Published: (2023)

Lycopene and <i>Garcinia cambogia</i> Induce White-to-Brown Adipose Differentiation: An Innovative Strategy to Curb Obesity
by: Federica Mannino, et al.
Published: (2024)

Evidence of Garcinia cambogia as a fat burning and appetite suppressing agents
by: Wan Nur Asyiken Wan Ab Rahman, et al.
Published: (2016)

The effects of Garcinia cambogia (hydroxycitric acid) on serum leptin concentrations: A systematic review and meta-analysis of randomized controlled trials
by: Mohammad Reza Amini, et al.
Published: (2024)

Continuum of non-alcoholic fatty liver disease: from hepatic steatosis to cardiovascular risk
by: O. M. Drapkina, et al.
Published: (2016)

Development of a novel human triculture model of non-alcoholic fatty liver disease and identification of berberine as ameliorating steatosis, oxidative stress and fibrosis
by: Hossein Rafiei, et al.
Published: (2023)

Pharmacological Activity of <i>Garcinia indica</i> (Kokum): An Updated Review
by: Sung Ho Lim, et al.
Published: (2021)

Long-term effects of Garcinia cambogia/Glucomannan on weight loss in people with obesity, PLIN4, FTO and Trp64Arg polymorphisms
by: Andrea Maia-Landim, et al.
Published: (2018)

Modulation of serotonin in the gut-liver neural axis ameliorates the fatty and fibrotic changes in non-alcoholic fatty liver
by: Masayoshi Ko, et al.
Published: (2021)

BCATc inhibitor 2 ameliorated mitochondrial dysfunction and apoptosis in oleic acid-induced non-alcoholic fatty liver disease model
by: Zhuo Lu, et al.
Published: (2022)

Correction: Modulation of serotonin in the gut-liver neural axis ameliorates the fatty and fibrotic changes in non-alcoholic fatty liver
by: Masayoshi Ko, et al.
Published: (2023)

<i>Helicobacter Pylori</i> infection and non-alcoholic fatty liver disease. Is there a relationship?
by: Neveen Rashad Mostafa, et al.
Published: (2023)

Diagnostic accuracy of apoptosis markers in non-alcoholic fatty liver disease in children
by: Yu. M. Stepanov, et al.
Published: (2020)

Effect of <i>Gracilaria vermiculophylla</i> Macroalga on Non-Alcoholic Fatty Liver Disease in Obese Rats
by: Maitane González-Arceo, et al.
Published: (2024)

Beneficial Effects of Capybara Oil Supplementation on Steatosis and Liver Apoptosis in Obese Mice
by: Luciana Lontro Alves, et al.
Published: (2024)

Therapeutic roles of a natural herbal product on ameliorating hepatic steatosis via gut dysbacteriosis modulating in treatment of nonalcoholic fatty liver disease in mice
by: Xiaoan Ren, et al.
Published: (2021)

Hydroxytyrosol attenuates ethanol-induced liver injury by ameliorating steatosis, oxidative stress and hepatic inflammation by interfering STAT3/iNOS pathway
by: Xianying Fang, et al.
Published: (2023)

Ultrasound Score of Liver Steatosis Severity in the Diagnosis of Peripheral Arterial Atherosclerosis in Patients with Nonalcoholic Fatty Liver Disease
by: A. S. Kuznetsova, et al.
Published: (2023)

Stevia and Stevioside Attenuate Liver Steatosis through PPARα-Mediated Lipophagy in <i>db/db</i> Mice Hepatocytes
by: Miey Park, et al.
Published: (2022)

Triglyceride Glucose Index is Associated with Ultrasonographic Fatty Liver Indicator in Children and Adolescents with Non-alcoholic Fatty Liver Disease
by: Bitgyeol Kim, et al.
Published: (2024)

<i>Orthosiphon aristatus</i> (Blume) Miq Alleviates Non-Alcoholic Fatty Liver Disease via Antioxidant Activities in C57BL/6 Obese Mice and Palmitic-Oleic Acid-Induced Steatosis in HepG2 Cells
by: Salah Abdalrazak Alshehade, et al.
Published: (2023)

Association between smoking cessation and non-alcoholic fatty liver disease using NAFLD liver fat score
by: Yun Seo Jang, et al.
Published: (2023)

Lycorine ameliorates liver steatosis, oxidative stress, ferroptosis and intestinal homeostasis imbalance in MASLD mice
by: Ziwen Wang, et al.
Published: (2024)

Gentiana scabra Restrains Hepatic Pro-Inflammatory Macrophages to Ameliorate Non-Alcoholic Fatty Liver Disease
by: Yiyuan Zheng, et al.
Published: (2022)

Puerarin ameliorates non-alcoholic fatty liver disease by inhibiting lipid metabolism through FMO5
by: Zhaoyi Li, et al.
Published: (2024)

Enzyme-Treated <i>Zizania latifolia</i> Extract Protects against Alcohol-Induced Liver Injury by Regulating the NRF2 Pathway
by: Bo Yoon Chang, et al.
Published: (2021)

Demethylcalabaxanthone from <i>Garcinia mangostana</i> Exerts Antioxidant Effects through the Activation of the Nrf2 Pathway as Assessed via Molecular Docking and Biological Evaluation
by: Simona De Vita, et al.
Published: (2023)

Neddylation inhibition ameliorates steatosis in NAFLD by boosting hepatic fatty acid oxidation via the DEPTOR-mTOR axis
by: Marina Serrano-Maciá, et al.
Published: (2021)

Dynamics of hepatic steatosis resolution and changes in gut microbiome with weight loss in nonalcoholic fatty liver disease
by: Jaideep Behari, et al.
Published: (2021)

Lipophagy and Alcohol-Induced Fatty Liver
by: Li Yang, et al.
Published: (2019)

Combined impact of myosteatosis and liver steatosis on prognosis in stage I-III colorectal cancer patients
by: Dong Hee Lee, et al.
Published: (2023)

The additive effect of herbal medicines on lifestyle modification in the treatment of non-alcoholic fatty liver disease: a systematic review and meta-analysis
by: Myung-Ho Kim, et al.
Published: (2024)

Shenling Baizhu San ameliorates non-alcoholic fatty liver disease in mice by modulating gut microbiota and metabolites
by: Dongliang Chen, et al.
Published: (2024)

<i>Caesalpinia sappan</i> Linn. Ameliorates Allergic Nasal Inflammation by Upregulating the Keap1/Nrf2/HO-1 Pathway in an Allergic Rhinitis Mouse Model and Nasal Epithelial Cells
by: Bo-Jeong Pyun, et al.
Published: (2022)

The combination of blueberry juice and probiotics reduces apoptosis of alcoholic fatty liver of mice by affecting SIRT1 pathway
by: Zhu J, et al.
Published: (2016)

Liver Antioxidant Capacity and Steatosis in Laying Hens Exposed to Various Quantities of Lupin (<i>Lupinus angustifolius</i>) Seeds in the Diet
by: Marta Wójcik, et al.
Published: (2024)

Alcohol Abstinence Rescues Hepatic Steatosis and Liver Injury via Improving Metabolic Reprogramming in Chronic Alcohol-Fed Mice
by: Aiwen Pi, et al.
Published: (2021)

The effect of DASH diet on atherogenic indices, pro-oxidant-antioxidant balance, and liver steatosis in obese adults with non-alcoholic fatty liver disease: A double-blind controlled randomized clinical trial
by: Taghi Badali, et al.
Published: (2023)

The effects of grape seed extract supplementation on cardiovascular risk factors, liver enzymes and hepatic steatosis in patients with non-alcoholic fatty liver disease: a randomised, double-blind, placebo-controlled study
by: Parisa Ghanbari, et al.
Published: (2024)